The Merck index, 12th Ed., Merck and Co. Inc., White House Stations, NJ, pp. 1205 (1997).
 Current Index of Medical Specialities (CIMS), CMP Medica India Pvt Ltd., Bangalore, India, July-October, pp. 76 (2005).
 Ding, G., Tang, A., Wang, J., Cong, R. and Bao, J., Direct Enantioseparation of Pantoprazole Sodium by High Performance Liquid Chromatography on Teicoplanin-Bonded Chiral Stationary Phase, Sepu., 24, 46 (2006), 2006 ACS on Scifinder; CAN 144:199119; AN 2006:141860.
 Ding, G., Cong, R., and Wang, J., Direct Enantio Separation of Pantoprazole Sodium by High Performance Liquid Chromatography, Sepu., 22, 241 (2004), 2006 ACS on Scifinder; CAN 141:59853; AN 2004:563455.
 Xue-Hui, H. and Fu-Sheng, P., Determination of Pantoprazole Sodium in Capsules by HPLC, Zhongguo Yiyao Gongye Zazhi, 31, 502 (2000), ACS on Scifinder; CAN 134:91243; AN 2001:52063.
 Agbaba, D., Novovic, D., Karljikovic-Rajic, K. and Marinkovic, V., Densitometric Determination of Omeprazole, Pantoprazole, and their Impurities in Pharmaceuticals, J. Planar Chromatogr. Mod. TLC., 17, 169 (2004).
 Karljikovic-Rajic, K., Novovic, D., Marinkovic, V. and Agbaba, D., First-order UV-Derivative Spectrophotometry in the Analysis of Omeprazole and Pantoprazole Sodium Salt and Corresponding Impurities, J. Pharm. Biomed., Anal., 32, 1019 (2003).
 Wahbi Abdel-Aziz, M., Abdel-Razak, O., Gazy, A. A., Mahgoub, H., and Moneeb, M. S., Spectro-photometric Determination of Omeprazole, Lansoprazole and Pantoprazole in Pharmaceutical Formulations, J. Pharm. Biomed. Anal., 30, 1133 (2002).
 Salama, F., El-Abasawy, N., Razeq, S. A. A., Ismail, M. F. and Fouad, M. M., Spectrophotometric Determination of Omeprazole and Pantoprazole Sodium via Chelates with Iron, Chromium, and Cobalt, Bull. Fac. Pharm (Cairo University), 41, 185 (2003).
 Moustafa, A. A. M., Spectrophotometric Methods for the Determination of Lansoprazole and Panto-prazole Sodium Sesquihydrate, J. Pharm. Biomed. Anal., 22, 45 (2000).
 Berka, A., Vulterin, J. and Zyka, J., Newer Redox Titrants (Pergamon Press, London) 38(1965).
 International Conference on Hormonisation of Technical Requirements for Registration of Pharma-ceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2 (R1), Complementary Guideline on Methodology dated 06 November 1996, incorporated in November 2005, London.